SECURE CLOUD ACCESS
IF THERE IS NO EARLY DIAGNOSIS,
THEN THERE IS NO TIMELY TREATMENT
AUTONOMIC NERVOUS SYSTEM
AND VASCULAR ASSESSMENTS
AND VASCULAR ASSESSMENTS
LD PRODUCTS: EARLY DETECTION OF DIABETES COMPLICATIONS
AUTONOMIC NERVOUS SYSTEM AND VASCULAR FUNCTION ASSESSMENTS
BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS
Monitoring and treatment.
Management of hypertension,
HEART RATE VARIABILITY (HRV)
Cardiac Autonomic Dysfunction Assessment.
PHOTOPLETHYSMOGRAPHY
Mathematical Analysis of the
pulse Ox wave.
pulse Ox wave.
CARDIAC AUTONOMIC REFLEX TESTs (CARTs)
Cardiac Autonomic Neuropathy Assessment.
SUDOMOTOR
FUNCTION TESTS
ANKLE BRAKIAL INDEX (ABI)
Peripheral Artery Disease (PAD).
Blood flow blockage or calcification.
CMicrocirculation and
small fiber Assessments
small fiber Assessments
MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION
FATIGUE
HEADACHE
DIZZINESS
EXERCISE INTOLERANCE
FAINTING
TINGLING IN THE TOES OR FINGERS
CLAUDICATION
PAINFUL MUSCLE CRAMPING IN THE HIPS, THIGHS OR CALVES WHEN WALKING, CLIMBING STAIRS OR EXERCING.
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION IN THE USA.
50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic).
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic).
70+
Population over 70 years old.
OVER 45 MILLIONS PEOPLE
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH LD PRODUCTS
NEW INTERFACES : THE PAD SERIES
ADAPTED TO THE HEALTH PROFESSIONAL NEEDS
DOWNLOAD LD PRODUCTS CATALOG